215 related articles for article (PubMed ID: 11870517)
21. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
22. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
[TBL] [Abstract][Full Text] [Related]
24. Highly differentiated keratinizing squamous cell cancer of the cervix.
Rubinstein E
Am J Surg Pathol; 2002 May; 26(5):676; author reply 676. PubMed ID: 11979099
[No Abstract] [Full Text] [Related]
25. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
27. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Jabbar SF; Abrams L; Glick A; Lambert PF
Cancer Res; 2009 May; 69(10):4407-14. PubMed ID: 19435895
[TBL] [Abstract][Full Text] [Related]
28. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.
Alazawi W; Pett M; Strauss S; Moseley R; Gray J; Stanley M; Coleman N
Br J Cancer; 2004 Dec; 91(12):2063-70. PubMed ID: 15545968
[TBL] [Abstract][Full Text] [Related]
29. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer.
Singh A; Sharma H; Salhan S; Gupta SD; Bhatla N; Jain SK; Singh N
Pathobiology; 2004; 71(6):314-22. PubMed ID: 15627842
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia.
Monsonego J; Valensi P; Zerat L; Clavel C; Birembaut P
Br J Obstet Gynaecol; 1997 Jun; 104(6):723-7. PubMed ID: 9197877
[TBL] [Abstract][Full Text] [Related]
33. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
Cox JT
Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
[TBL] [Abstract][Full Text] [Related]
35. Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.
Bekkers RL; Bulten J; Wiersma-van Tilburg A; Mravunac M; Schijf CP; Massuger LF; Quint WG; Melchers WJ
Br J Cancer; 2003 Sep; 89(5):886-90. PubMed ID: 12942122
[TBL] [Abstract][Full Text] [Related]
36. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
37. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
Kraus I; Molden T; Holm R; Lie AK; Karlsen F; Kristensen GB; Skomedal H
J Clin Microbiol; 2006 Apr; 44(4):1310-7. PubMed ID: 16597856
[TBL] [Abstract][Full Text] [Related]
38. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions.
Tonon SA; Picconi MA; Bos PD; Zinovich JB; Galuppo J; Alonio LV; Teyssie AR
J Clin Virol; 2001 May; 21(2):129-34. PubMed ID: 11378493
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer research focuses on the HPV E7 gene.
Senior K
Lancet Oncol; 2002 Oct; 3(10):585. PubMed ID: 12372711
[No Abstract] [Full Text] [Related]
40. PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix.
Cenci M; Pisani T; French D; Alderisio M; Vecchione A
Anticancer Res; 2005; 25(3B):2187-92. PubMed ID: 16158962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
